VA disability ratings to ignore medication benefits—veterans may lose compensation
S. 4140 — Carlton H. Ingram Veterans’ Benefits Protection Act · Filed by Richard Blumenthal (D-CT) · 7 cosponsors · Introduced Mar 19, 2026 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the VA's disability rating schedule to require that ratings be based on a veteran's condition WITHOUT the benefit of medication or treatment, establishing a baseline disability level. However, veterans can still claim additional compensation if the medication or treatment itself causes new disabilities or worsens existing ones. The practical effect is that a veteran whose condition is well-controlled by medication will receive a disability rating reflecting their underlying condition, not their medicated state.
Why we flagged it
The bill is a technical amendment to the statutory framework governing how the VA calculates disability ratings. It does not create new benefits or cut them outright; it changes the baseline against which ratings are measured — from current functional state (with medication) to underlying condition (without medication). This is a methodological shift with real distributional consequences.
What the text implies
- Veterans whose conditions are well-managed by medication may experience rating reductions and corresponding compensation cuts, even if their underlying disability severity has not changed. The bill does not grandfather existing ratings, so implementation could affect current beneficiaries.
- The bill creates a two-tier claim process: one for the baseline disability (without medication effects) and a separate claim for medication/treatment-caused harms. Veterans must navigate both to recover full compensation, increasing administrative burden and litigation risk.
The full analysis lists 4 implications of this text.
Who it affects
Veterans with well-controlled conditions via medication may see lower disability ratings and reduced compensation, a concrete cost. However, the bill explicitly preserves the right to claim separate compensation for medication side effects or treatment-caused aggravation, and it clarifies the rating methodology in statute rather than leaving it to VA discretion, which is a transparency gain.